Mirum Pharmaceuticals (MIRM) Ownership - Who Owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals (MIRM) Ownership Overview
- 7.53% Insiders
- 33.86% Mutual Funds
- 0.35% Other Institutional Investors
- 14.95% ETFs
- 43.30% Public Companies and Individual Investors
The ownership structure of Mirum Pharmaceuticals (MX:MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 49.17% of the company’s stock is owned by Institutional Investors, 7.53% is owned by Insiders, and 43.30% is owned by Public Companies and Individual Investors.
The ownership structure of Mirum Pharmaceuticals (MX:MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 49.17% of the company’s stock is owned by Institutional Investors, 7.53% is owned by Insiders, and 43.30% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 18, 2026 | Jolanda Howe | $4,000,000 | |
| Feb 02, 2026 | Peter Radovich | $271,782 | |
| Feb 02, 2026 | Christopher Peetz | $940,856 | |
| Jan 26, 2026 | Patrick Heron | $8,999,984 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 4,853,706 | Institution | 7.48% | 382,782,670 |
| BlackRock, Inc. | 4,390,063 | Institution | 6.76% | 346,217,928 |
| Vanguard Index Funds | 4,074,911 | Institution | 6.28% | 321,363,781 |
| Patrick Heron | 4,031,625 | Insider | 6.21% | 317,950,074 |
| Ishares | 2,435,055 | Institution | 3.75% | 192,038,178 |
| Janus Investment Fund | 1,869,951 | Institution | 2.88% | 147,471,816 |
| Spdr | 1,453,354 | Institution | 2.24% | 114,617,310 |
| Fidelity Rutland Square Trust Ii | 1,341,982 | Institution | 2.07% | 105,834,068 |
| Mutual Fund Series Trust | 1,284,393 | Institution | 1.98% | 101,292,370 |
| Smallcap World Fund Inc | 1,123,070 | Institution | 1.73% | 88,569,792 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,074,911 | Institution | 6.28% | 321,363,781 |
| Janus Investment Fund | 1,869,951 | Institution | 2.88% | 147,471,816 |
| Fidelity Rutland Square Trust Ii | 1,341,982 | Institution | 2.07% | 105,834,068 |
| Mutual Fund Series Trust | 1,284,393 | Institution | 1.98% | 101,292,370 |
| Smallcap World Fund Inc | 1,123,070 | Institution | 1.73% | 88,569,792 |
| Fidelity Securities Fund | 856,480 | Institution | 1.32% | 67,545,439 |
| T. Rowe Price New Horizons Fund, Inc. | 823,454 | Institution | 1.27% | 64,940,876 |
| Fidelity Salem Street Trust | 681,979 | Institution | 1.05% | 53,783,592 |
| Fidelity Concord Street Trust | 589,145 | Institution | 0.91% | 46,462,331 |
| Lazard Funds Inc | 567,136 | Institution | 0.87% | 44,726,614 |
FAQ
Who Owns Mirum Pharmaceuticals (MX:MIRM)?
According to the latest TipRanks data, approximately 49.17% of the company's stock is held by institutional investors, 7.53% is held by insiders, and 43.30% is held by public companies and individual investors.
What percentage of Mirum Pharmaceuticals (MX:MIRM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 49.17% of Mirum Pharmaceuticals (MX:MIRM) stock is held by institutional investors: 33.86% by mutual funds, 14.95% by ETFs and 0.35% by other institutional investors.
What percentage of Mirum Pharmaceuticals (MX:MIRM) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.30% of Mirum Pharmaceuticals (MX:MIRM) stock is held by public companies and individual investors.
Who owns the most shares of Mirum Pharmaceuticals (MX:MIRM)?
Vanguard owns the most shares of Mirum Pharmaceuticals (MX:MIRM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
